Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Respiratory Medicine and Research
|
November 20, 2022
Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19
Bas F M van Raaij, J Lauran Stöger, Chris Hinnen, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
May 15, 2009
The Latin American Consortium of Studies in Obesity (LASO)
L E Bautista, J P Casas, V M Herrera, et al.
RMD Open
|
April 7, 2023
Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
Sophie I E Liem, Jacopo Ciaffi, Nina Marijn van Leeuwen, et al.
International Journal of Obesity (2005)
|
February 25, 2009
Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease
V M Herrera, J P Casas, J J Miranda, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 10, 2025
The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization
Chantal Visser, Julia C Berentschot, Cindy M M de Jong, et al.
The Journal of Allergy and Clinical Immunology
|
June 3, 2024
Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response
Jelle M Blankestijn, Nadia Baalbaki, Somayeh Bazdar, et al.
BMJ Open Respiratory Research
|
April 25, 2024
Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium
Jelle M Blankestijn, Mahmoud I Abdel-Aziz, Nadia Baalbaki, et al.
Journal of Personalized Medicine
|
July 29, 2023
Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension
Nadia Baalbaki, Jelle M Blankestijn, Mahmoud I Abdel-Aziz, et al.
The Lancet. Respiratory Medicine
|
June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Jurjan Aman, Erik Duijvelaar, Liza Botros, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Respiratory Medicine and Research
|
November 20, 2022
Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19
Bas F M van Raaij, J Lauran Stöger, Chris Hinnen, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
May 15, 2009
The Latin American Consortium of Studies in Obesity (LASO)
L E Bautista, J P Casas, V M Herrera, et al.
RMD Open
|
April 7, 2023
Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
Sophie I E Liem, Jacopo Ciaffi, Nina Marijn van Leeuwen, et al.
International Journal of Obesity (2005)
|
February 25, 2009
Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease
V M Herrera, J P Casas, J J Miranda, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 10, 2025
The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization
Chantal Visser, Julia C Berentschot, Cindy M M de Jong, et al.
The Journal of Allergy and Clinical Immunology
|
June 3, 2024
Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response
Jelle M Blankestijn, Nadia Baalbaki, Somayeh Bazdar, et al.
BMJ Open Respiratory Research
|
April 25, 2024
Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium
Jelle M Blankestijn, Mahmoud I Abdel-Aziz, Nadia Baalbaki, et al.
Journal of Personalized Medicine
|
July 29, 2023
Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension
Nadia Baalbaki, Jelle M Blankestijn, Mahmoud I Abdel-Aziz, et al.
The Lancet. Respiratory Medicine
|
June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Jurjan Aman, Erik Duijvelaar, Liza Botros, et al.
Page
of 6